SLSSELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on developing novel therapies for cancer. SELLAS Life Sciences Group, Inc. concentrates on immunotherapeutic and targeted oncology programs designed to address a broad range of hematologic and solid tumor indications. Its current pipeline includes product candidates aimed at cancers such as acute myeloid leukemia, reflecting its emphasis on disease areas with significant unmet medical need. The company’s work centers on advancing clinical-stage assets through research and development, with a business model built around innovative cancer treatment platforms rather than commercialized consumer products. Headquartered in New York, SELLAS Life Sciences Group, Inc. plays a role in the biotechnology market as a specialist developer of experimental oncology therapies.